Pancreatic surgery during the COVID-19 pandemic 2020-2021: an observational cohort study from a third level referral center.
COVID
Lockdown effect
Pancreatic surgery
Volume
Waiting time
Journal
BMC surgery
ISSN: 1471-2482
Titre abrégé: BMC Surg
Pays: England
ID NLM: 100968567
Informations de publication
Date de publication:
21 May 2022
21 May 2022
Historique:
received:
12
02
2022
accepted:
06
05
2022
entrez:
21
5
2022
pubmed:
22
5
2022
medline:
25
5
2022
Statut:
epublish
Résumé
During the COVID pandemic there has been limited access to elective surgery including oncologic surgery in several countries world-wide. The aim of this study was to investigate if there was any lockdown effect on pancreatic surgery with special focus on malignant pancreatic and periampullary tumours. Patients who underwent pancreatic surgery during the two Danish lockdown periods from 11. March 2020 and the following 12 months were compared with patients who were operated the preceding 3 years. Data on patients' characteristics, waiting time, operations, and clinical outcomes were evaluated. During lockdown and the previous three years the annual number of resections were 242, 232, 253, and 254, respectively (p = 0.851). Although the numbers were not significantly different, there were fluctuations in operations and waiting time during the lockdown. During the second outbreak of COVID October 2020 to March 2021 the overall median waiting time increased to 33 days (quartiles 26;39) compared to 23 (17;33) days during the first outbreak from March to May 2020 (p = 0.019). The same difference was seen for patients with malignant tumours, 30 (23;36) vs. 22 (18;30) months (p = 0.001). However, the fluctuations and waiting time during lockdown was like the preceding three years. Neither 30- nor 90-days mortality, length of stay, number of extended operations, and complications and tumour stage were significantly different from previous years. There were significant fluctuations in waiting time for operations during the lockdown, but these variations were not different from the preceding three years, wherefore other explanations than an impact from COVID are conceivable.
Sections du résumé
BACKGROUND
BACKGROUND
During the COVID pandemic there has been limited access to elective surgery including oncologic surgery in several countries world-wide. The aim of this study was to investigate if there was any lockdown effect on pancreatic surgery with special focus on malignant pancreatic and periampullary tumours.
METHODS
METHODS
Patients who underwent pancreatic surgery during the two Danish lockdown periods from 11. March 2020 and the following 12 months were compared with patients who were operated the preceding 3 years. Data on patients' characteristics, waiting time, operations, and clinical outcomes were evaluated.
RESULTS
RESULTS
During lockdown and the previous three years the annual number of resections were 242, 232, 253, and 254, respectively (p = 0.851). Although the numbers were not significantly different, there were fluctuations in operations and waiting time during the lockdown. During the second outbreak of COVID October 2020 to March 2021 the overall median waiting time increased to 33 days (quartiles 26;39) compared to 23 (17;33) days during the first outbreak from March to May 2020 (p = 0.019). The same difference was seen for patients with malignant tumours, 30 (23;36) vs. 22 (18;30) months (p = 0.001). However, the fluctuations and waiting time during lockdown was like the preceding three years. Neither 30- nor 90-days mortality, length of stay, number of extended operations, and complications and tumour stage were significantly different from previous years.
CONCLUSIONS
CONCLUSIONS
There were significant fluctuations in waiting time for operations during the lockdown, but these variations were not different from the preceding three years, wherefore other explanations than an impact from COVID are conceivable.
Identifiants
pubmed: 35597984
doi: 10.1186/s12893-022-01651-7
pii: 10.1186/s12893-022-01651-7
pmc: PMC9124050
doi:
Types de publication
Journal Article
Observational Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
200Informations de copyright
© 2022. The Author(s).
Références
World J Clin Oncol. 2021 Feb 24;12(2):54-60
pubmed: 33680873
Ann Oncol. 2020 Aug;31(8):1065-1074
pubmed: 32442581
Br J Surg. 2020 Aug;107(9):1097-1103
pubmed: 32293715
Colorectal Dis. 2020 Jun;22(6):625-634
pubmed: 32233064
Ann Med Surg (Lond). 2021 Nov 06;72:103026
pubmed: 34820121
Oncologist. 2021 Jan;26(1):
pubmed: 32845538
Ann Surg. 2020 Aug;272(2):e87-e93
pubmed: 32675507
Acta Oncol. 2022 May;61(5):658-661
pubmed: 35020549
Eur J Epidemiol. 2014 Aug;29(8):541-9
pubmed: 24965263
Ann Surg. 2020 Aug;272(2):e106-e111
pubmed: 32675511
Ann Surg. 2009 Aug;250(2):187-96
pubmed: 19638912
Pancreatology. 2016 Jan-Feb;16(1):14-27
pubmed: 26699808
J Surg Oncol. 2021 Jul;124(1):7-15
pubmed: 33765341
Cancer Med. 2020 Dec;9(24):9205-9218
pubmed: 33078903
Ann Surg. 2020 Jun 2;:
pubmed: 32487802
Ann Surg Open. 2021 Jun 10;2(2):e071
pubmed: 34240077
Br J Surg. 2020 Oct;107(11):1440-1449
pubmed: 32395848
BMJ Open. 2020 Oct 31;10(10):e042392
pubmed: 33130573
Langenbecks Arch Surg. 2020 May;405(3):293-302
pubmed: 32447457
Ann Surg. 2020 Aug;272(2):e112-e117
pubmed: 32675512
Anaesthesia. 2021 Jul;76(7):940-946
pubmed: 33735942
Int J Surg. 2020 Jul;79:180-188
pubmed: 32454253